相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals
Jasper van der Lugt et al.
ANTIVIRAL THERAPY (2009)
Saquinavir, the pioneer antiretroviral protease inhibitor
Charles J. L. la Porte
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy
Jade Ghosn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women
Matthieu Roustit et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: Mechanisms, tissue specificity, and time course
Huixia Zhang et al.
MOLECULAR PHARMACOLOGY (2008)
Clinical pharmacology of HIV protease inhibitors in pregnancy
Jasper van der Lugt et al.
CURRENT OPINION IN HIV AND AIDS (2008)
Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer
Diego Ripamonti et al.
AIDS (2007)
Pharmacokinetic modelling of the placental transfer of nelfinavir and its M8 metabolite: a population study using 75 maternal-cord plasma samples
Deborah Hirt et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Steady-state lopinavir levels in third trimester of pregnancy
Fiona Lyons et al.
AIDS (2007)
Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy
Luis F. Lopez-Cortes et al.
THERAPEUTIC DRUG MONITORING (2007)
Plasma lopinavir trough levels in a group of pregnant women on lopinavir, ritonavir, zidovudine, and lamivudine
Kaveh Manavi et al.
AIDS (2007)
Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women
Jashvant D. Unadkat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy
Nils von Hentig et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women
P. Villani et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers
Alan Winston et al.
AIDS (2006)
Changes in pharmacokinetics of anti-HIV protease inhibitors during pregnancy: The role of CYP3A and P-glycoprotein
AA Mathias et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects
I Sanne et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women
EP Acosta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pharmacokinetics of antiretrovirals in pregnant women
M Mirochnick et al.
CLINICAL PHARMACOKINETICS (2004)
Analysis of generic nevirapine products in developing countries
SR Penzak et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Myelomeningocele in a child with intrauterine exposure to efavirenz
C Fundarò et al.
AIDS (2002)
Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure
M Mirochnick et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors
EP Acosta et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
